Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responders to proton pump inhibitors

Digestive and Liver Disease

Volumn 44, Issue 7, 2012, Pages 549-554

  Ribolsi, Mentore ^a   Emerenziani, Sara ^a   Petitti, Tommasangelo ^a   Addarii, Maria Chiara ^a   Balestrieri, Paola ^a   Cicala, Michele ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

NERD; Oesophageal sensitivity; PPI resistance

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPARATIVE STUDY; ESOPHAGUS MUCOSA; ESOPHAGUS PH; FEMALE; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; IMPEDANCE; INCIDENCE; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; PRIORITY JOURNAL; REPEAT PROCEDURE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ESOPHAGEAL PH MONITORING; FEMALE; GASTRIC JUICE; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; LARYNGOPHARYNGEAL REFLUX; LOGISTIC MODELS; MALE; MIDDLE AGED; PERCEPTION; PROTON PUMP INHIBITORS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84861339329     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.01.007     Document Type: Article

References (24)

1. Quigley E.M., DiBaise J.K. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Dig Liver Dis 2001, 33:523-527.
2. Dean B.B., Gano A.D., Knight K., et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004, 2:656-664.
3. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006, 55:1398-1402.
4. Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006, 101:1956-1963.
5. Frazzoni M., Conigliaro R., Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci 2011, 56:1099-1106.
6. Broeders J.A., Bredenoord A.J., Hazebroek E.J., et al. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut 2011, 60:435-441.
7. Nagahara A., Miwa H., Minoo T., et al. Increased esophageal sensitivity to acid and saline in patients with non erosive gastroesophageal reflux disease. J Clin Gastroenterol 2006, 40:891-895.
8. Trimble K.C., Pryde A., Heading R.C. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995, 37:7-12.
9. Cicala M., Emerenziani S., Caviglia R., et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003, 18:605-613.
10. Cicala M., Habib F.I., Emerenziani S. Proximal oesophagus: the added value in understanding GORD symptoms. Neurogastroenterol Motil 2009, 21:790-795.
11. Emerenziani S., Sifrim D., Habib F.I., et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 2008, 57:443-447.
12. Tutuian R., Vela M.F., Hill E.G., et al. Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol 2008, 103:1090-1096.
13. Zerbib F., Duriez A., Roman S., et al. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008, 57:156-160.
14. Hemmink G.J., Bredenoord A.J., Weusten B.L., et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor. Am J Gastroenterol 2008, 103:2446-2453.
15. Shaw M.J., Talley N.J., Beebe T.J., et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001, 96:52-57.
16. Weusten B.L., Roelofs J.M., Akkermans L.M., et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994, 1071:1741-1745.
17. Hosmer D.W., Lemeshow S. Applied Logistic Regression, II edition. Wiley Series 2000, Wiley-Interscience publication, New York.
18. Sharma N., Agrawal A., Freeman J., et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol 2008, 6:521-524.
19. Savarino E., Zentilin P., Tutuian R., et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008, 103:2685-2693.
20. Zerbib F., des Varannes S.B., Roman S., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005, 22:1011-1021.
21. Zentilin P., Iiritano E., Dulbecco P., et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis 2006, 38:226-232.
22. Matthews P.J., Knowles C.H., Chua Y.C., et al. Effects of the concentration and frequency of acid infusion on the development and maintenance of esophageal hyperalgesia in a human volunteer model. Am J Physiol Gastrointest Liver Physiol 2008, 294:G914-G917.
23. Farré R., van Malenstein H., De Vos R., et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 2008, 57:1366-1374.
24. Vela M.F., Craft B.M., Sharma N., et al. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs functional heartburn. Am J Gastroenterol 2011, 106:844-850.